FDA Updates for the Week of Jan. 16, 2023
FDA Updates for the Week of Jan. 16, 2023 unknown
FDA approves Brukinsa for chronic lymphocytic leukemia.
he FDA has
FDA Updates for the Week of Jan. 9, 2023
FDA Updates for the Week of Jan. 9, 2023 unknown
FDA approves Rybelsus for first-line treatment of diabetes.
The FDA
FDA Updates for the Week of Jan. 3, 2023
FDA Updates for the Week of Jan. 3, 2023 unknown
FDA approves Alzheimer’s medication lecanemab.
The FDA has issued
FDA Updates for the Week of Dec. 19, 2022
FDA Updates for the Week of Dec. 19, 2022 unknown
FDA approves first bispecific antibody for follicular lymphoma.
The FDA